ArticleCell death & disease2022

Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma.

Zhen-Yuan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.